Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

CE certificate

  • Home
  •  
  • CE certificate



  • Most Read
  • Latest Comments
  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Federal budget’s funding boost for HIV self-testing kit ups Atomo Diagnostics morale
    Federal budget’s funding boost for HIV self-testing kit ups Atomo Diagnostics morale
    • News

  • Atomo’s HIV self-test kits head to low income countries with $970k Viatris order
    Atomo’s HIV self-test kits head to low income countries with $970k Viatris order
    • News

  • HIV, Covid and pregnancy tests drive Atomo revenue growth in Q2 FY24
    HIV, Covid and pregnancy tests drive Atomo revenue growth in Q2 FY24
    • News

  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • News

  • Atomo Diagnostics expands HIV self-test kits to South Africa as HIV rate hikes
    Atomo Diagnostics expands HIV self-test kits to South Africa as HIV rate hikes
    • News

  • Atomo lands $2.1m deal to supply HIV self-test kits for European distribution
    • News

    Atomo lands $2.1m deal to supply HIV self-test kits for European distribution

    Roughly two months after securing a supply order for HIV Self-Test kit for the South African market back in April 2023, medical diagnostics company Atomo Diagnostics (ASX: AT1) has further bolstered its project portfolio through an exclusive supply agreement with UK-based Newfoundland Diagnostics. This agreement focuses on HIV rapid testing in the European market. HIV

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.